Document type: drug_safety_update
There are 806 pages with document type ‘drug_safety_update’ in the GOV.UK search index.
Rendering apps
This document type is rendered by:
Supertypes
| Type | Group |
|---|---|
| User journey | thing |
| Email document type | other |
| Government document type | other |
| Content Purpose Subgroup | updates_and_alerts |
| Content Purpose Supergroup | news_and_communications |
Content schemas
This document type is allowed by the schema:
Example pages
- Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products
- Letters and medicine recalls sent to healthcare professionals in October 2023
- E-cigarette use or vaping: reminder to remain vigilant for suspected adverse reactions and safety concerns and report them to the Yellow Card scheme
- Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir
- Over-the-counter painkillers containing codeine or dihydrocodeine
- Isotretinoin (Roaccutane▼): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age
- Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure
- Codeine linctus: public consultation on the proposal to reclassify to a prescription-only medicine
- Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects
- Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects